Amgen Inc. Share Price
NASDAQ: AMGN | Mega CapAmgen Inc. Stock Performance
Open $433.92 | Prev. Close $437.00 | Circuit Range N/A |
Day Range $430.75 - $434.26 | Year Range $269.85 - $447.03 | Volume 1,15,634 |
Average Traded $432.32 |
Amgen Inc. Share Price Today
As of 30 August 2026, Amgen Inc.'s share price is $432.33. The stock opened at $433.92, compared to its previous close of $437.00. During today's trading session, Amgen Inc.'s share price traded between $430.75 and $434.26, with an average price of $432.50. Over the past 52 weeks, the stock has recorded a high of $447.03 and a low of $269.85. In terms of performance, Amgen Inc.'s share price has risen by 11.40% over the last six months and is up 50.34% on a year-on-year basis.
Amgen Inc. Share Price Chart
Amgen Inc. Stock Fundamentals & Key Indicators
Market Cap $232.59B | PE Ratio (TTM) 30.17 | Dividend Yield 2.20% |
EPS (TTM) $14.33 | Revenue (TTM) $36.75B | Return On Equity (TTM) 89.06% |
Profit Margin 20.98% | Debt to Equity 2.94 | Quarterly Earnings Growth YoY 13.64% |
Amgen Inc. Quarterly Profit & Loss
All figures in USD
Amgen Inc. Annual Profit & Loss
All figures in USD
About Amgen Inc.
Amgen Inc., based in Thousand Oaks, California, is a global biotechnology company focused on developing human therapeutics. It specializes in oncology, nephrology, and inflammation treatments. Amgen is known for drugs like Enbrel, Neulasta, and Repatha.
Amgen Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $389.64 | $436.92 | +13.42% |
Jul 2026 | $362.47 | $385.21 | +6.37% |
Jun 2026 | $333.00 | $362.15 | +7.54% |
May 2026 | $334.89 | $336.77 | -2.73% |
Apr 2026 | $354.90 | $346.22 | -1.61% |
Mar 2026 | $386.63 | $351.87 | -9.33% |
Feb 2026 | $340.82 | $388.10 | +13.48% |
Jan 2026 | $328.69 | $341.99 | +4.47% |
Dec 2025 | $343.14 | $327.35 | -5.23% |
Nov 2025 | $298.44 | $345.43 | +15.74% |
Oct 2025 | $285.27 | $298.44 | +5.76% |
Sep 2025 | $288.05 | $282.18 | -1.87% |